Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name GAS5
   Synonyms GAS5, NCRNA00030, SNHG2, ENST00000456293.5, GAS5-007
   Region GRCh38_1:173863900-173868882    Sequence
   Ensembl ENSG00000234741
   RefSeq NR_002578
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name prostate cancer
   ICD-0-3 C61.9  
   Methods qPCR, RNA interference and transient transfection etc.
   Sample prostate cancer tissues, cell lines (LNCaP, 22RV1, DU145, PC3, WPMY-1)
   Expression Pattern up-regulated
   Function Description

GAS5-007 was reduced by androgen treatment and inhibited by AR. Functional analysis of GAS5 showed it was related to regulating translational elongation, protein biosynthesis, and transcription. Moreover, we observed GAS5-007 knockdown inhibited the proliferation, cell cycle and promoted cell apoptosis of PCa. We also constructed a GAS5-miRNA network to explain the different roles of different GAS5 transcripts in PCa. This study provides novel insights to identify potential diagnostic biomarker and therapy target for prostate cancer in clinical treatment.

   Pubmed ID 28771526
   Year 2017
   Title An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.
   External Links
   Links for  GAS5 GenBank       HGNC       lncrnadb       Noncode
   Links for  prostate cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.